Q1 26 EPS
$1.00
BEAT +8.28%
Est. $0.92
Q1 26 Revenue
$474.4M
BEAT +8.73%
Est. $436.3M
Did PIPR Beat Earnings? Q1 2026 Results
Piper Sandler Companies posted a strong first quarter, with earnings per share of $1.00 beating the $0.92 consensus estimate by 8.28% and revenue of $474.41 million clearing Wall Street expectations by 8.73%, as the investment bank reported year-over… Read more Piper Sandler Companies posted a strong first quarter, with earnings per share of $1.00 beating the $0.92 consensus estimate by 8.28% and revenue of $474.41 million clearing Wall Street expectations by 8.73%, as the investment bank reported year-over-year revenue growth of 36.4%. The headline driver was a sharp rebound in corporate investment banking, where financing revenues more than doubled year-over-year to $73.31 million, led by a healthcare franchise that ranked among the top biopharma equity underwriters, while advisory revenues of $250.96 million grew 16% on the back of 69 completed M&A and restructuring transactions, up from 42 a year ago. Pre-tax margin expanded meaningfully to 18.5% from 8.2% in the year-ago period, and the board signaled confidence by lifting its quarterly dividend 14% to $0.20 per share, with shares having already rallied sharply in recent weeks ahead of the print. Management acknowledged that trade policy uncertainty, geopolitical conditions, and interest rate volatility could weigh on deal activity and fixed income revenues in coming quarters.
Key Takeaways
- • Record first quarter corporate investment banking revenues driven by 30% YoY growth
- • Corporate financing revenues more than doubled YoY led by healthcare franchise as No. 2 biopharma equity underwriter
- • Advisory services revenues up 16% YoY driven by increased M&A and debt capital markets advisory activity
- • Healthcare franchise delivered a record advisory quarter
- • Equity brokerage achieved strongest first quarter on record leveraging elevated market volatility
- • Fixed income benefited from balance sheet restructuring trades offsetting regular-way activity decline
- • Total completed advisory transactions increased 71% YoY to 94
- • Book run equity transactions priced rose 136% YoY to 26
PIPR Forward Guidance & Outlook
Management noted it remains actively engaged with clients to help them navigate current uncertainty. Forward-looking risk factors highlight potential impacts from trade policy including tariffs, continued business and investor uncertainty around geopolitical conditions, and interest rate volatility that could negatively impact the fixed income institutional business. Revenue from corporate advisory and financing engagements may vary materially depending on number, size, and timing of completed transactions.
PIPR YoY Financials
Q1 2026 vs Q1 2025, source: SEC Filings
PIPR Revenue by Segment
With YoY comparisons, source: SEC Filings
“We started 2026 strong, delivering record first quarter revenues powered by a 30% growth in corporate investment banking over last year.”
— Chad Abraham, Q1 2026 Earnings Press Release
PIPR Earnings Trends
PIPR vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
PIPR EPS Trend
Earnings per share: estimate vs actual
PIPR Revenue Trend
Quarterly revenue: estimate vs actual
PIPR Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $0.92 | $1.00 | +8.28% | $474.4M | +8.73% |
| Q4 25 BEAT FY | $4.76 | $6.88 | +44.48% | $635.0M | +22.55% |
| FY Full Year | $15.56 | $17.74 | +14.00% | $1.88B | +6.63% |
| Q3 25 BEAT | $3.27 | $3.82 | +16.73% | $479.3M | +13.17% |
| Q2 25 BEAT | $2.23 | $2.95 | +32.44% | $396.8M | +11.74% |
| Q1 25 BEAT | $2.85 | $4.09 | +43.76% | $357.3M | -2.84% |